Yahoo Web Search

  1. Ads
    related to MERCK & COMPANY INC
  1. Yahoo Finance Results

  2. Merck & Co Inc. (NYSE:MRK): Time For A Financial Health Check

    Simply Wall St. via Yahoo FinanceMay 06 11:47 AM

    Merck & Co Inc. (NYSE:MRK), a large-cap worth US$155.50B, comes to mind for investors seeking a strong and reliable stock...are attracted to diversified streams of revenue and ...

  3. Merck & Co Inc. (NYSE:MRK) Is Trading At A 31% Discount

    Simply Wall St. via Yahoo FinanceMay 15 0:35 AM

    How far off is Merck & Co Inc. (NYSE:MRK) from its intrinsic value? Using the most recent financial data, I am going to take a look at whether the stock is fairly priced using ...

  4. Better Buy: Pfizer Inc. (PFE) vs. Merck (MRK)

    Motley Fool via Yahoo FinanceMay 13 10:31 AM

    All three of these apply to Pfizer (NYSE: PFE), but they also all apply to Merck (NYSE: MRK). Although quarterly results present only a snapshot of a company's performance, it's ...

  5. This could indicate that investors who seek to profit from falling equity prices are not currently targeting MRK. Index (PMI) data, output in the Healthcare sector is rising.

  6. Merck & Co., Inc. MRK and Pfizer, Inc. PFE reported upbeat first-quarter results on May 1. Merckhas...possesses a Zacks Rank #3 (Hold). In the first quarter, Merck ...

  7. Merck KGaA (MKGAF) Q1 Earnings and Revenues Decline Y/Y

    Zacks via Yahoo FinanceMay 15 14:32 PM

    Merck KGaA MKGAF reported first-quarter 2018 earnings of $1.73 per American Depositary Share. Earnings per share declined 21.7% in local currency. Net sales in the reported quarter came ...

  8. President Donald Trump on Friday unveiled his plans of lowering drug prices, in keeping with promises he made in the run-up to the Presidential elections. Pharmaceutical companies and the broader ...

  9. What's in the Cards for Merck KGaA (MKGAF) in Q1 Earnings?

    Zacks via Yahoo FinanceMay 14 13:40 PM

    Merck KGaA MKGAF is scheduled to report first-quarter 2018 results on May 15. Merck’s shares have declined 11.1% so far this year against the industry’s rally of 0.8%. Merck ...

  10. ImmunoGen, Inc. IMGN reported adjusted loss of 30 cents per share for the first quarter of 2018, wider than the Zacks Consensus Estimate of a loss...s shares were down 3.9% on May 4 presumably ...

  11. Mersana Therapeutics Inc (NASDAQ: MRSN) is closing out its first year as a public company, and in that time it’s cleared an investigational new drug application and earned endorsements ...

  1. Ads
    related to MERCK & COMPANY INC